Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alexander G. Turpie
McMaster University
Study Chair - William D. Fisher, MD
Department of Orthopaedic Surgery, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec, H3G 1A4, Canada
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sanofi-Aventis Administrative Office
Buenos Aires, Argentina
- Sanofi-Aventis Administrative Office
Minsk, Belarus
- Sanofi-Aventis Administrative Office
Sofia, Bulgaria
- Sanofi-Aventis Administrative Office
Laval, Canada
- Sanofi-Aventis Administrative Office
Santiago, Chile
- Sanofi-Aventis Administrative Office
Shangaï, China
- Sanofi-Aventis Administrative Office
Bogotá, Colombia
- Sanofi-Aventis Administrative Office
Prague, Czechia
- Sanofi-Aventis Administrative Office
Hørsholm, Denmark
- Sanofi-Aventis Administrative Office
Helsinki, Finland
- Sanofi-Aventis Administrative Office
Athens, Greece
- Sanofi-Aventis Administrative Office
Mumbai, India
- Sanofi-Aventis Administrative Office
Milan, Italy
- Sanofi-Aventis Administrative Office
México, Mexico
- Sanofi-Aventis Administrative Office
Lima, Peru
- Sanofi-Aventis Administrative Office
Warsaw, Poland
- Sanofi-Aventis Administrative Office
Porto Salvo, Portugal
- Sanofi-Aventis Administrative Office
Bucharest, Romania
- Sanofi-Aventis Administrative Office
Moscow, Russia
- Sanofi-Aventis Administrative Office
Midrand, South Africa
- Sanofi-Aventis Administrative Office
Barcelona, Spain
- Sanofi-Aventis Administrative Office
Bromma, Sweden
- Sanofi-Aventis Administrative Office
Istanbul, Turkey (Türkiye)
- Sanofi-Aventis Administrative Office
Kiev, Ukraine
- Sanofi-Aventis Administrative Office
Bridgewater, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2008
- Primary completion
- 31 Oct 2009
- Completion
- 31 Oct 2009
- Last update posted
- 23 Jan 2013
- Registered enrollment
- 1,003
- Registry id
- NCT00721760
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.